AnnouncementsWockhardt: Outcome of board meeting
AnnouncementsWockhardt appoints Manas Datta as CFO
AnnouncementsWockhardt appoints Nimesh Shah as company secretary
75% of moneycontrol users recommend buying Wockhardt.
What's your call on Wockhardt today?
Read 4 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3200.60||-0.88||3353.85||2420.00||54,527.29|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
National Buildings Constr Recommended on Jul 14th 2014
Recommended price 396.00 | Peak from reco 767.50 93.69%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Wockhardt is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 8,861.69 crore.The company has reported a consolidated sales of Rs 991.19 crore and a Net Profit of Rs 22.21 crore for the quarter ended Jun 2014.
The company management includes Habil Khorakiwala - Chairman & Group CEO, Murtaza Khorakiwala - Managing Director, Huzaifa Khorakiwala - Executive Director, R A Shah - Director, Aman Mehta - Director, Shekhar Datta - Director, D S Brar - Director, Sanjaya Baru - Director.
It is listed on the BSE with a BSE Code of 532300 and the NSE with an NSE Code of WOCKPHARMA.
Its Registered office is at Wockhardt Towers, Bandra-Kurla Complex,,Bandra (East) Mumbai,Maharashtra - 400051.
Their Registrars are Link Intime India Pvt. Ltd.